Research shows glycosylation patterns of immunogens influence HIV vaccine design, suggesting potential efficacy improvements.
RNA-based vaccines have emerged as a highly effective delivery platform. However, this approach eliminates the possibility for immunogen purification, common in manufacturing of recombinant immunogens. In HIV-1 vaccine design, this...
No takes yet. Share an insight, caveat, or question.
Chawla et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: